Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Hoque A, Albanes D, Lippman SM, Spitz MR, Taylor PR, Klein EA, Thompson IM, Goodman P, Stanford JL, Crowley JJ, Coltman CA, Santella RM.

Cancer Causes Control. 2001 Sep;12(7):627-33.

PMID:
11552710
2.

SELECT: the selenium and vitamin E cancer prevention trial.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

Urol Oncol. 2003 Jan-Feb;21(1):59-65. Review.

PMID:
12684129
3.

SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

J Urol. 2001 Oct;166(4):1311-5.

PMID:
11547064
4.

Selenium and vitamin E cancer prevention trial.

Klein EA.

Ann N Y Acad Sci. 2004 Dec;1031:234-41. Review.

PMID:
15753149
5.

The selenium and vitamin E cancer prevention trial.

Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

World J Urol. 2003 May;21(1):21-7. Epub 2003 Mar 8. Review.

PMID:
12756490
6.

The future of prostate cancer prevention.

Brawley OW, Barnes S, Parnes H.

Ann N Y Acad Sci. 2001 Dec;952:145-52. Review.

PMID:
11795434
7.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864. Epub 2008 Dec 9.

8.

Update on chemoprevention of prostate cancer.

Klein EA, Thompson IM.

Curr Opin Urol. 2004 May;14(3):143-9. Review.

PMID:
15069304
9.

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA Jr.

J Natl Cancer Inst. 2005 Jan 19;97(2):94-102.

PMID:
15657339
10.

Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.

Pak RW, Lanteri VJ, Scheuch JR, Sawczuk IS.

Integr Cancer Ther. 2002 Dec;1(4):338-44. Review.

PMID:
14664728
11.

A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Dunn BK, Richmond ES, Minasian LM, Ryan AM, Ford LG.

Nutr Cancer. 2010;62(7):896-918. doi: 10.1080/01635581.2010.509833. Review.

PMID:
20924966
12.

Moving a randomized clinical trial into an observational cohort.

Goodman PJ, Hartline JA, Tangen CM, Crowley JJ, Minasian LM, Klein EA, Cook ED, Darke AK, Arnold KB, Anderson K, Yee M, Meyskens FL, Baker LH.

Clin Trials. 2013 Feb;10(1):131-42. doi: 10.1177/1740774512460345. Epub 2012 Oct 12.

13.

Prostate cancer prevention: what do we know now and when will we know more?

Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B.

Clin Prostate Cancer. 2003 Mar;1(4):215-20. Review.

PMID:
15040879
14.

Update on prostate cancer chemoprevention.

Lowe JF, Frazee LA.

Pharmacotherapy. 2006 Mar;26(3):353-9. Review.

PMID:
16503715
15.
16.

Prevention of prostate cancer.

DePrimo SE, Shinghal R, Vidanes G, Brooks JD.

Hematol Oncol Clin North Am. 2001 Jun;15(3):445-57. Review.

PMID:
11525290
17.

Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.

Thompson IM, Coltman CA Jr, Crowley J.

Prostate. 1997 Nov 1;33(3):217-21.

PMID:
9365551
18.

Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?

Moyad MA.

Urology. 2002 Apr;59(4 Suppl 1):9-19. Review.

PMID:
11937432
19.

The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.

Platz EA, Giovannucci E.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):237-53. Epub 2005 Jan 5. Review.

PMID:
15663987
20.

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1262-9.

Supplemental Content

Support Center